BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 26800490)

  • 1. Chronic lymphocytic leukemia: Time to go past genomics?
    Roos-Weil D; Nguyen-Khac F; Bernard OA
    Am J Hematol; 2016 May; 91(5):518-28. PubMed ID: 26800490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular pathogenesis of CLL and its evolution.
    Rodríguez D; Bretones G; Arango JR; Valdespino V; Campo E; Quesada V; López-Otín C
    Int J Hematol; 2015 Mar; 101(3):219-28. PubMed ID: 25630433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular pathogenesis of chronic lymphocytic leukemia.
    Gaidano G; Foà R; Dalla-Favera R
    J Clin Invest; 2012 Oct; 122(10):3432-8. PubMed ID: 23023714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The complex interplay between cell-intrinsic and cell-extrinsic factors driving the evolution of chronic lymphocytic leukemia.
    Sutton LA; Rosenquist R
    Semin Cancer Biol; 2015 Oct; 34():22-35. PubMed ID: 25963298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonal evolution in chronic lymphocytic leukemia: impact of subclonality on disease progression.
    Sutton LA; Rosenquist R
    Expert Rev Hematol; 2015 Feb; 8(1):71-8. PubMed ID: 25345442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene mutations in chronic lymphocytic leukemia.
    Amin NA; Malek SN
    Semin Oncol; 2016 Apr; 43(2):215-21. PubMed ID: 27040699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developing Molecular Signatures for Chronic Lymphocytic Leukemia.
    Cornet E; Debliquis A; Rimelen V; Civic N; Docquier M; Troussard X; Drénou B; Matthes T
    PLoS One; 2015; 10(6):e0128990. PubMed ID: 26046539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution.
    Mao Z; Quintanilla-Martinez L; Raffeld M; Richter M; Krugmann J; Burek C; Hartmann E; Rudiger T; Jaffe ES; Müller-Hermelink HK; Ott G; Fend F; Rosenwald A
    Am J Surg Pathol; 2007 Oct; 31(10):1605-14. PubMed ID: 17895764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biclonality versus intraclonal evolution of a single tumor cell clone in B-cell chronic lymphoproliferative disorders.
    Dunphy CH
    Haematologica; 2006 Mar; 91(3):292A. PubMed ID: 16531249
    [No Abstract]   [Full Text] [Related]  

  • 10. Evolving understanding of the CLL genome.
    Gruber M; Wu CJ
    Semin Hematol; 2014 Jul; 51(3):177-87. PubMed ID: 25048782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SnapShot: Chronic Lymphocytic Leukemia.
    Ten Hacken E; Guièze R; Wu CJ
    Cancer Cell; 2017 Nov; 32(5):716-716.e1. PubMed ID: 29136511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valproic acid induces apoptosis in chronic lymphocytic leukemia cells through activation of the death receptor pathway and potentiates TRAIL response.
    Lagneaux L; Gillet N; Stamatopoulos B; Delforge A; Dejeneffe M; Massy M; Meuleman N; Kentos A; Martiat P; Willems L; Bron D
    Exp Hematol; 2007 Oct; 35(10):1527-37. PubMed ID: 17697742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of new putative driver mutations and predictors of disease evolution in chronic lymphocytic leukemia.
    Mosquera Orgueira A; Antelo Rodríguez B; Díaz Arias JÁ; Bello López JL
    Blood Cancer J; 2019 Sep; 9(10):78. PubMed ID: 31570692
    [No Abstract]   [Full Text] [Related]  

  • 14. Epigenetic dysregulation of the Wnt signalling pathway in chronic lymphocytic leukaemia.
    Chim CS; Pang R; Liang R
    J Clin Pathol; 2008 Nov; 61(11):1214-9. PubMed ID: 18765431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B cell chronic lymphocytic leukemia: lessons learned from studies of the B cell antigen receptor.
    Chiorazzi N; Ferrarini M
    Annu Rev Immunol; 2003; 21():841-94. PubMed ID: 12615894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of DNA methylation is linked to genetic aberrations in chronic lymphocytic leukemia.
    Oakes CC; Claus R; Gu L; Assenov Y; Hüllein J; Zucknick M; Bieg M; Brocks D; Bogatyrova O; Schmidt CR; Rassenti L; Kipps TJ; Mertens D; Lichter P; Döhner H; Stilgenbauer S; Byrd JC; Zenz T; Plass C
    Cancer Discov; 2014 Mar; 4(3):348-61. PubMed ID: 24356097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The genetic landscape of chronic lymphocytic leukemia].
    Marosvári D; Alpár D; Király AP; Rajnai H; Reiniger L; Bödör C
    Magy Onkol; 2016 Jun; 60(2):118-25. PubMed ID: 27275638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
    Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
    Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic and epigenomic heterogeneity in chronic lymphocytic leukemia.
    Guièze R; Wu CJ
    Blood; 2015 Jul; 126(4):445-53. PubMed ID: 26065654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deciphering the molecular landscape in chronic lymphocytic leukemia: time frame of disease evolution.
    Sutton LA; Rosenquist R
    Haematologica; 2015 Jan; 100(1):7-16. PubMed ID: 25552678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.